What is the projected market valuation of the Tissue Banking Market by 2035?

The Tissue Banking Market is projected to reach a valuation of 8.0 USD Billion by 2035. Read More

What was the market valuation of the Tissue Banking Market in 2024?

In 2024, the Tissue Banking Market was valued at 4.528 USD Billion. Read More

What is the expected CAGR for the Tissue Banking Market from 2025 to 2035?

The expected CAGR for the Tissue Banking Market during the forecast period 2025 - 2035 is 5.31%. Read More

Which application segment is expected to show significant growth in the Tissue Banking Market?

The Regenerative Medicine application segment is anticipated to grow from 1.5 USD Billion in 2024 to 2.5 USD Billion by 2035. Read More

What are the key types of tissue banks in the market?

The key types of tissue banks include Cell Banks, Organ Banks, and Tissue Banks, with Tissue Banks projected to grow from 2.028 USD Billion to 3.7 USD Billion by 2035. Read More

Which storage method is expected to dominate the Tissue Banking Market?

Chemical Preservation is expected to dominate, with a projected growth from 2.028 USD Billion in 2024 to 3.7 USD Billion by 2035. Read More

What are the primary end-use segments for the Tissue Banking Market?

The primary end-use segments include Hospitals, Research Institutions, and Pharmaceutical Companies, with Pharmaceutical Companies expected to grow from 1.828 USD Billion to 3.5 USD Billion by 2035. Read More

Who are the leading players in the Tissue Banking Market?

Key players in the Tissue Banking Market include Tissue Regenix Group, AlloSource, and CryoLife, among others. Read More

How does the Tissue Banking Market's growth compare across different applications?

The Drug Discovery application segment is projected to grow from 1.2 USD Billion in 2024 to 2.0 USD Billion by 2035, indicating robust growth. Read More

What trends are influencing the Tissue Banking Market in 2025?

Trends such as advancements in regenerative medicine and increased demand for organ transplants are influencing the Tissue Banking Market in 2025. Read More

Tissue Banking Market

Tissue Banking Market Research Report: Size, Share, Trend Analysis By Applications (Regenerative Medicine, Drug Discovery, Tissue Engineering, Transplantation), By Types of Tissue Bank (Cell Bank, Organ Bank, Tissue Bank), By Storage Method (Cryopreservation, Lyophilization, Chemical Preservation), By End-use (Hospitals, Research Institutions, Pharmaceutical Companies), and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth Outlook & Industry Forecast 2025 To 2035

Forecast Period

2025 - 2035

CAGR

5.31%

2024 Market Size

$ 4.53 Billion

2035 Market Size

$ 8 Billion

Healthcare ● Updated August 2026 Report ID: MRFR/HC/10884-HCR | Pages: 200 | Author: Vikita Thakur, Rahul Gotadki

Summary Table of Contents Segmentation Download PDF

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Healthcare, BY Application (USD Billion)
  1. 4.1.1 Regenerative Medicine
  2. 4.1.2 Drug Discovery
  3. 4.1.3 Tissue Engineering
  4. 4.1.4 Transplantation
2. 4.2 Healthcare, BY Type of Tissue Bank (USD Billion)
  1. 4.2.1 Cell Bank
  2. 4.2.2 Organ Bank
  3. 4.2.3 Tissue Bank
3. 4.3 Healthcare, BY Storage Method (USD Billion)
  1. 4.3.1 Cryopreservation
  2. 4.3.2 Lyophilization
  3. 4.3.3 Chemical Preservation
4. 4.4 Healthcare, BY End-use (USD Billion)
  1. 4.4.1 Hospitals
  2. 4.4.2 Research Institutions
  3. 4.4.3 Pharmaceutical Companies
5. 4.5 Healthcare, BY Region (USD Billion)
  1. 4.5.1 North America
    1. 4.5.1.1 US
    2. 4.5.1.2 Canada
  2. 4.5.2 Europe
    1. 4.5.2.1 Germany
    2. 4.5.2.2 UK
    3. 4.5.2.3 France
    4. 4.5.2.4 Russia
    5. 4.5.2.5 Italy
    6. 4.5.2.6 Spain
    7. 4.5.2.7 Rest of Europe
  3. 4.5.3 APAC
    1. 4.5.3.1 China
    2. 4.5.3.2 India
    3. 4.5.3.3 Japan
    4. 4.5.3.4 South Korea
    5. 4.5.3.5 Malaysia
    6. 4.5.3.6 Thailand
    7. 4.5.3.7 Indonesia
    8. 4.5.3.8 Rest of APAC
  4. 4.5.4 South America
    1. 4.5.4.1 Brazil
    2. 4.5.4.2 Mexico
    3. 4.5.4.3 Argentina
    4. 4.5.4.4 Rest of South America
  5. 4.5.5 MEA
    1. 4.5.5.1 GCC Countries
    2. 4.5.5.2 South Africa
    3. 4.5.5.3 Rest of MEA
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Healthcare
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Tissue Regenix Group (GB)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 AlloSource (US)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Mediware Information Systems (US)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 CryoLife (US)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Organogenesis (US)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Acelity (US)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Tissue Bank (AU)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Bioventus (US)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
  9. 5.2.9 LifeNet Health (US)
    1. 5.2.9.1 Financial Overview
    2. 5.2.9.2 Products Offered
    3. 5.2.9.3 Key Developments
    4. 5.2.9.4 SWOT Analysis
    5. 5.2.9.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 NORTH AMERICA MARKET ANALYSIS
3. 6.3 US MARKET ANALYSIS BY APPLICATION
4. 6.4 US MARKET ANALYSIS BY TYPE OF TISSUE BANK
5. 6.5 US MARKET ANALYSIS BY STORAGE METHOD
6. 6.6 US MARKET ANALYSIS BY END-USE
7. 6.7 CANADA MARKET ANALYSIS BY APPLICATION
8. 6.8 CANADA MARKET ANALYSIS BY TYPE OF TISSUE BANK
9. 6.9 CANADA MARKET ANALYSIS BY STORAGE METHOD
10. 6.10 CANADA MARKET ANALYSIS BY END-USE
11. 6.11 EUROPE MARKET ANALYSIS
12. 6.12 GERMANY MARKET ANALYSIS BY APPLICATION
13. 6.13 GERMANY MARKET ANALYSIS BY TYPE OF TISSUE BANK
14. 6.14 GERMANY MARKET ANALYSIS BY STORAGE METHOD
15. 6.15 GERMANY MARKET ANALYSIS BY END-USE
16. 6.16 UK MARKET ANALYSIS BY APPLICATION
17. 6.17 UK MARKET ANALYSIS BY TYPE OF TISSUE BANK
18. 6.18 UK MARKET ANALYSIS BY STORAGE METHOD
19. 6.19 UK MARKET ANALYSIS BY END-USE
20. 6.20 FRANCE MARKET ANALYSIS BY APPLICATION
21. 6.21 FRANCE MARKET ANALYSIS BY TYPE OF TISSUE BANK
22. 6.22 FRANCE MARKET ANALYSIS BY STORAGE METHOD
23. 6.23 FRANCE MARKET ANALYSIS BY END-USE
24. 6.24 RUSSIA MARKET ANALYSIS BY APPLICATION
25. 6.25 RUSSIA MARKET ANALYSIS BY TYPE OF TISSUE BANK
26. 6.26 RUSSIA MARKET ANALYSIS BY STORAGE METHOD
27. 6.27 RUSSIA MARKET ANALYSIS BY END-USE
28. 6.28 ITALY MARKET ANALYSIS BY APPLICATION
29. 6.29 ITALY MARKET ANALYSIS BY TYPE OF TISSUE BANK
30. 6.30 ITALY MARKET ANALYSIS BY STORAGE METHOD
31. 6.31 ITALY MARKET ANALYSIS BY END-USE
32. 6.32 SPAIN MARKET ANALYSIS BY APPLICATION
33. 6.33 SPAIN MARKET ANALYSIS BY TYPE OF TISSUE BANK
34. 6.34 SPAIN MARKET ANALYSIS BY STORAGE METHOD
35. 6.35 SPAIN MARKET ANALYSIS BY END-USE
36. 6.36 REST OF EUROPE MARKET ANALYSIS BY APPLICATION
37. 6.37 REST OF EUROPE MARKET ANALYSIS BY TYPE OF TISSUE BANK
38. 6.38 REST OF EUROPE MARKET ANALYSIS BY STORAGE METHOD
39. 6.39 REST OF EUROPE MARKET ANALYSIS BY END-USE
40. 6.40 APAC MARKET ANALYSIS
41. 6.41 CHINA MARKET ANALYSIS BY APPLICATION
42. 6.42 CHINA MARKET ANALYSIS BY TYPE OF TISSUE BANK
43. 6.43 CHINA MARKET ANALYSIS BY STORAGE METHOD
44. 6.44 CHINA MARKET ANALYSIS BY END-USE
45. 6.45 INDIA MARKET ANALYSIS BY APPLICATION
46. 6.46 INDIA MARKET ANALYSIS BY TYPE OF TISSUE BANK
47. 6.47 INDIA MARKET ANALYSIS BY STORAGE METHOD
48. 6.48 INDIA MARKET ANALYSIS BY END-USE
49. 6.49 JAPAN MARKET ANALYSIS BY APPLICATION
50. 6.50 JAPAN MARKET ANALYSIS BY TYPE OF TISSUE BANK
51. 6.51 JAPAN MARKET ANALYSIS BY STORAGE METHOD
52. 6.52 JAPAN MARKET ANALYSIS BY END-USE
53. 6.53 SOUTH KOREA MARKET ANALYSIS BY APPLICATION
54. 6.54 SOUTH KOREA MARKET ANALYSIS BY TYPE OF TISSUE BANK
55. 6.55 SOUTH KOREA MARKET ANALYSIS BY STORAGE METHOD
56. 6.56 SOUTH KOREA MARKET ANALYSIS BY END-USE
57. 6.57 MALAYSIA MARKET ANALYSIS BY APPLICATION
58. 6.58 MALAYSIA MARKET ANALYSIS BY TYPE OF TISSUE BANK
59. 6.59 MALAYSIA MARKET ANALYSIS BY STORAGE METHOD
60. 6.60 MALAYSIA MARKET ANALYSIS BY END-USE
61. 6.61 THAILAND MARKET ANALYSIS BY APPLICATION
62. 6.62 THAILAND MARKET ANALYSIS BY TYPE OF TISSUE BANK
63. 6.63 THAILAND MARKET ANALYSIS BY STORAGE METHOD
64. 6.64 THAILAND MARKET ANALYSIS BY END-USE
65. 6.65 INDONESIA MARKET ANALYSIS BY APPLICATION
66. 6.66 INDONESIA MARKET ANALYSIS BY TYPE OF TISSUE BANK
67. 6.67 INDONESIA MARKET ANALYSIS BY STORAGE METHOD
68. 6.68 INDONESIA MARKET ANALYSIS BY END-USE
69. 6.69 REST OF APAC MARKET ANALYSIS BY APPLICATION
70. 6.70 REST OF APAC MARKET ANALYSIS BY TYPE OF TISSUE BANK
71. 6.71 REST OF APAC MARKET ANALYSIS BY STORAGE METHOD
72. 6.72 REST OF APAC MARKET ANALYSIS BY END-USE
73. 6.73 SOUTH AMERICA MARKET ANALYSIS
74. 6.74 BRAZIL MARKET ANALYSIS BY APPLICATION
75. 6.75 BRAZIL MARKET ANALYSIS BY TYPE OF TISSUE BANK
76. 6.76 BRAZIL MARKET ANALYSIS BY STORAGE METHOD
77. 6.77 BRAZIL MARKET ANALYSIS BY END-USE
78. 6.78 MEXICO MARKET ANALYSIS BY APPLICATION
79. 6.79 MEXICO MARKET ANALYSIS BY TYPE OF TISSUE BANK
80. 6.80 MEXICO MARKET ANALYSIS BY STORAGE METHOD
81. 6.81 MEXICO MARKET ANALYSIS BY END-USE
82. 6.82 ARGENTINA MARKET ANALYSIS BY APPLICATION
83. 6.83 ARGENTINA MARKET ANALYSIS BY TYPE OF TISSUE BANK
84. 6.84 ARGENTINA MARKET ANALYSIS BY STORAGE METHOD
85. 6.85 ARGENTINA MARKET ANALYSIS BY END-USE
86. 6.86 REST OF SOUTH AMERICA MARKET ANALYSIS BY APPLICATION
87. 6.87 REST OF SOUTH AMERICA MARKET ANALYSIS BY TYPE OF TISSUE BANK
88. 6.88 REST OF SOUTH AMERICA MARKET ANALYSIS BY STORAGE METHOD
89. 6.89 REST OF SOUTH AMERICA MARKET ANALYSIS BY END-USE
90. 6.90 MEA MARKET ANALYSIS
91. 6.91 GCC COUNTRIES MARKET ANALYSIS BY APPLICATION
92. 6.92 GCC COUNTRIES MARKET ANALYSIS BY TYPE OF TISSUE BANK
93. 6.93 GCC COUNTRIES MARKET ANALYSIS BY STORAGE METHOD
94. 6.94 GCC COUNTRIES MARKET ANALYSIS BY END-USE
95. 6.95 SOUTH AFRICA MARKET ANALYSIS BY APPLICATION
96. 6.96 SOUTH AFRICA MARKET ANALYSIS BY TYPE OF TISSUE BANK
97. 6.97 SOUTH AFRICA MARKET ANALYSIS BY STORAGE METHOD
98. 6.98 SOUTH AFRICA MARKET ANALYSIS BY END-USE
99. 6.99 REST OF MEA MARKET ANALYSIS BY APPLICATION
100. 6.100 REST OF MEA MARKET ANALYSIS BY TYPE OF TISSUE BANK
101. 6.101 REST OF MEA MARKET ANALYSIS BY STORAGE METHOD
102. 6.102 REST OF MEA MARKET ANALYSIS BY END-USE
103. 6.103 KEY BUYING CRITERIA OF HEALTHCARE
104. 6.104 RESEARCH PROCESS OF MRFR
105. 6.105 DRO ANALYSIS OF HEALTHCARE
106. 6.106 DRIVERS IMPACT ANALYSIS: HEALTHCARE
107. 6.107 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
108. 6.108 SUPPLY / VALUE CHAIN: HEALTHCARE
109. 6.109 HEALTHCARE, BY APPLICATION, 2024 (% SHARE)
110. 6.110 HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Billion)
111. 6.111 HEALTHCARE, BY TYPE OF TISSUE BANK, 2024 (% SHARE)
112. 6.112 HEALTHCARE, BY TYPE OF TISSUE BANK, 2024 TO 2035 (USD Billion)
113. 6.113 HEALTHCARE, BY STORAGE METHOD, 2024 (% SHARE)
114. 6.114 HEALTHCARE, BY STORAGE METHOD, 2024 TO 2035 (USD Billion)
115. 6.115 HEALTHCARE, BY END-USE, 2024 (% SHARE)
116. 6.116 HEALTHCARE, BY END-USE, 2024 TO 2035 (USD Billion)
117. 6.117 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 North America MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.2.2 BY TYPE OF TISSUE BANK, 2025-2035 (USD Billion)
  3. 7.2.3 BY STORAGE METHOD, 2025-2035 (USD Billion)
  4. 7.2.4 BY END-USE, 2025-2035 (USD Billion)
2. 7.3 US MARKET SIZE ESTIMATES; FORECAST
  1. 7.3.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.3.2 BY TYPE OF TISSUE BANK, 2025-2035 (USD Billion)
  3. 7.3.3 BY STORAGE METHOD, 2025-2035 (USD Billion)
  4. 7.3.4 BY END-USE, 2025-2035 (USD Billion)
3. 7.4 Canada MARKET SIZE ESTIMATES; FORECAST
  1. 7.4.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.4.2 BY TYPE OF TISSUE BANK, 2025-2035 (USD Billion)
  3. 7.4.3 BY STORAGE METHOD, 2025-2035 (USD Billion)
  4. 7.4.4 BY END-USE, 2025-2035 (USD Billion)
4. 7.5 Europe MARKET SIZE ESTIMATES; FORECAST
  1. 7.5.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.5.2 BY TYPE OF TISSUE BANK, 2025-2035 (USD Billion)
  3. 7.5.3 BY STORAGE METHOD, 2025-2035 (USD Billion)
  4. 7.5.4 BY END-USE, 2025-2035 (USD Billion)
5. 7.6 Germany MARKET SIZE ESTIMATES; FORECAST
  1. 7.6.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.6.2 BY TYPE OF TISSUE BANK, 2025-2035 (USD Billion)
  3. 7.6.3 BY STORAGE METHOD, 2025-2035 (USD Billion)
  4. 7.6.4 BY END-USE, 2025-2035 (USD Billion)
6. 7.7 UK MARKET SIZE ESTIMATES; FORECAST
  1. 7.7.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.7.2 BY TYPE OF TISSUE BANK, 2025-2035 (USD Billion)
  3. 7.7.3 BY STORAGE METHOD, 2025-2035 (USD Billion)
  4. 7.7.4 BY END-USE, 2025-2035 (USD Billion)
7. 7.8 France MARKET SIZE ESTIMATES; FORECAST
  1. 7.8.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.8.2 BY TYPE OF TISSUE BANK, 2025-2035 (USD Billion)
  3. 7.8.3 BY STORAGE METHOD, 2025-2035 (USD Billion)
  4. 7.8.4 BY END-USE, 2025-2035 (USD Billion)
8. 7.9 Russia MARKET SIZE ESTIMATES; FORECAST
  1. 7.9.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.9.2 BY TYPE OF TISSUE BANK, 2025-2035 (USD Billion)
  3. 7.9.3 BY STORAGE METHOD, 2025-2035 (USD Billion)
  4. 7.9.4 BY END-USE, 2025-2035 (USD Billion)
9. 7.10 Italy MARKET SIZE ESTIMATES; FORECAST
  1. 7.10.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.10.2 BY TYPE OF TISSUE BANK, 2025-2035 (USD Billion)
  3. 7.10.3 BY STORAGE METHOD, 2025-2035 (USD Billion)
  4. 7.10.4 BY END-USE, 2025-2035 (USD Billion)
10. 7.11 Spain MARKET SIZE ESTIMATES; FORECAST
  1. 7.11.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.11.2 BY TYPE OF TISSUE BANK, 2025-2035 (USD Billion)
  3. 7.11.3 BY STORAGE METHOD, 2025-2035 (USD Billion)
  4. 7.11.4 BY END-USE, 2025-2035 (USD Billion)
11. 7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST
  1. 7.12.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.12.2 BY TYPE OF TISSUE BANK, 2025-2035 (USD Billion)
  3. 7.12.3 BY STORAGE METHOD, 2025-2035 (USD Billion)
  4. 7.12.4 BY END-USE, 2025-2035 (USD Billion)
12. 7.13 APAC MARKET SIZE ESTIMATES; FORECAST
  1. 7.13.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.13.2 BY TYPE OF TISSUE BANK, 2025-2035 (USD Billion)
  3. 7.13.3 BY STORAGE METHOD, 2025-2035 (USD Billion)
  4. 7.13.4 BY END-USE, 2025-2035 (USD Billion)
13. 7.14 China MARKET SIZE ESTIMATES; FORECAST
  1. 7.14.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.14.2 BY TYPE OF TISSUE BANK, 2025-2035 (USD Billion)
  3. 7.14.3 BY STORAGE METHOD, 2025-2035 (USD Billion)
  4. 7.14.4 BY END-USE, 2025-2035 (USD Billion)
14. 7.15 India MARKET SIZE ESTIMATES; FORECAST
  1. 7.15.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.15.2 BY TYPE OF TISSUE BANK, 2025-2035 (USD Billion)
  3. 7.15.3 BY STORAGE METHOD, 2025-2035 (USD Billion)
  4. 7.15.4 BY END-USE, 2025-2035 (USD Billion)
15. 7.16 Japan MARKET SIZE ESTIMATES; FORECAST
  1. 7.16.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.16.2 BY TYPE OF TISSUE BANK, 2025-2035 (USD Billion)
  3. 7.16.3 BY STORAGE METHOD, 2025-2035 (USD Billion)
  4. 7.16.4 BY END-USE, 2025-2035 (USD Billion)
16. 7.17 South Korea MARKET SIZE ESTIMATES; FORECAST
  1. 7.17.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.17.2 BY TYPE OF TISSUE BANK, 2025-2035 (USD Billion)
  3. 7.17.3 BY STORAGE METHOD, 2025-2035 (USD Billion)
  4. 7.17.4 BY END-USE, 2025-2035 (USD Billion)
17. 7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST
  1. 7.18.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.18.2 BY TYPE OF TISSUE BANK, 2025-2035 (USD Billion)
  3. 7.18.3 BY STORAGE METHOD, 2025-2035 (USD Billion)
  4. 7.18.4 BY END-USE, 2025-2035 (USD Billion)
18. 7.19 Thailand MARKET SIZE ESTIMATES; FORECAST
  1. 7.19.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.19.2 BY TYPE OF TISSUE BANK, 2025-2035 (USD Billion)
  3. 7.19.3 BY STORAGE METHOD, 2025-2035 (USD Billion)
  4. 7.19.4 BY END-USE, 2025-2035 (USD Billion)
19. 7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST
  1. 7.20.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.20.2 BY TYPE OF TISSUE BANK, 2025-2035 (USD Billion)
  3. 7.20.3 BY STORAGE METHOD, 2025-2035 (USD Billion)
  4. 7.20.4 BY END-USE, 2025-2035 (USD Billion)
20. 7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST
  1. 7.21.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.21.2 BY TYPE OF TISSUE BANK, 2025-2035 (USD Billion)
  3. 7.21.3 BY STORAGE METHOD, 2025-2035 (USD Billion)
  4. 7.21.4 BY END-USE, 2025-2035 (USD Billion)
21. 7.22 South America MARKET SIZE ESTIMATES; FORECAST
  1. 7.22.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.22.2 BY TYPE OF TISSUE BANK, 2025-2035 (USD Billion)
  3. 7.22.3 BY STORAGE METHOD, 2025-2035 (USD Billion)
  4. 7.22.4 BY END-USE, 2025-2035 (USD Billion)
22. 7.23 Brazil MARKET SIZE ESTIMATES; FORECAST
  1. 7.23.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.23.2 BY TYPE OF TISSUE BANK, 2025-2035 (USD Billion)
  3. 7.23.3 BY STORAGE METHOD, 2025-2035 (USD Billion)
  4. 7.23.4 BY END-USE, 2025-2035 (USD Billion)
23. 7.24 Mexico MARKET SIZE ESTIMATES; FORECAST
  1. 7.24.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.24.2 BY TYPE OF TISSUE BANK, 2025-2035 (USD Billion)
  3. 7.24.3 BY STORAGE METHOD, 2025-2035 (USD Billion)
  4. 7.24.4 BY END-USE, 2025-2035 (USD Billion)
24. 7.25 Argentina MARKET SIZE ESTIMATES; FORECAST
  1. 7.25.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.25.2 BY TYPE OF TISSUE BANK, 2025-2035 (USD Billion)
  3. 7.25.3 BY STORAGE METHOD, 2025-2035 (USD Billion)
  4. 7.25.4 BY END-USE, 2025-2035 (USD Billion)
25. 7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST
  1. 7.26.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.26.2 BY TYPE OF TISSUE BANK, 2025-2035 (USD Billion)
  3. 7.26.3 BY STORAGE METHOD, 2025-2035 (USD Billion)
  4. 7.26.4 BY END-USE, 2025-2035 (USD Billion)
26. 7.27 MEA MARKET SIZE ESTIMATES; FORECAST
  1. 7.27.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.27.2 BY TYPE OF TISSUE BANK, 2025-2035 (USD Billion)
  3. 7.27.3 BY STORAGE METHOD, 2025-2035 (USD Billion)
  4. 7.27.4 BY END-USE, 2025-2035 (USD Billion)
27. 7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST
  1. 7.28.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.28.2 BY TYPE OF TISSUE BANK, 2025-2035 (USD Billion)
  3. 7.28.3 BY STORAGE METHOD, 2025-2035 (USD Billion)
  4. 7.28.4 BY END-USE, 2025-2035 (USD Billion)
28. 7.29 South Africa MARKET SIZE ESTIMATES; FORECAST
  1. 7.29.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.29.2 BY TYPE OF TISSUE BANK, 2025-2035 (USD Billion)
  3. 7.29.3 BY STORAGE METHOD, 2025-2035 (USD Billion)
  4. 7.29.4 BY END-USE, 2025-2035 (USD Billion)
29. 7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST
  1. 7.30.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.30.2 BY TYPE OF TISSUE BANK, 2025-2035 (USD Billion)
  3. 7.30.3 BY STORAGE METHOD, 2025-2035 (USD Billion)
  4. 7.30.4 BY END-USE, 2025-2035 (USD Billion)
30. 7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.31.1
1. 7.32 ACQUISITION/PARTNERSHIP
7.32.1

Certified Researchers

Customize Report

Tissue Banking Market Segmentation

Tissue Banking Market By Application (USD Billion, 2025-2035)

Regenerative Medicine
Drug Discovery
Tissue Engineering
Transplantation

Tissue Banking Market By Type of Tissue Bank (USD Billion, 2025-2035)

Cell Bank
Organ Bank
Tissue Bank

Tissue Banking Market By Storage Method (USD Billion, 2025-2035)

Cryopreservation
Lyophilization
Chemical Preservation

Tissue Banking Market By End-use (USD Billion, 2025-2035)

Hospitals
Research Institutions
Tissue Banking Market Companies

Certified Researchers

Customize Report

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”

Rob Kooiker Group Product Manager HVAC & Fire Protection GMA

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

“The Automotive 48V ECU Components Procurement Intelligence Study” was a complex project, but the Market Research Future (MRFR) team handled it with quality, agility, and customer-centricity. They delivered all requested data on time and within the agreed scope. The team, including Shubhendra Anand and Rahul Gotadki, was always readily available to clarify questions and swiftly implement necessary adjustments, driving the project to a successful conclusion within a very demanding timeframe.
I would also like to specifically commend Akshay Agarwal for his responsiveness and support at every stage—from our initial inquiry on May 6th through to final delivery on June 18th. His dedication made the entire process seamless.”